Orgenesis Inc.
Orgenesis Inc. (ORGS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ORGS · as of Jun 30, 2024
Ownership Breakdown
18
Institutional Holders
▲ 2 vs Q1
$931,618
Total Inst. Value
▼ $365,086 vs Q1
5.17M
Shares Outstanding
freeFloat 66.78%
1.55M
13F Shares Held
▼ 24,649 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ORGS largest shareholders · institutional ownership
Q2 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 910.3K | 2.74% | 2.74% | $546.15M | Aug 13, 2024 | ▼ 14.9K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 283.1K | 85.32% | 85.32% | $169.87M | Aug 9, 2024 | ▼ 4.9K |
BLACKROCK INC. pharmaceutical preparations | 79.9K | 24.08% | 24.08% | $47.93M | Aug 13, 2024 | ▼ 45.3K |
STATE STREET CORP pharmaceutical preparations | 78.9K | 23.78% | 23.78% | $47.33M | Aug 14, 2024 | ▲ 11.2K |
NORTHERN TRUST CORP pharmaceutical preparations | 40.5K | 12.21% | 12.21% | $24.31M | Aug 14, 2024 | ▼ 161 |
BANK HAPOALIM BM pharmaceutical preparations | 32.1K | 9.66% | 9.66% | $19.00M | Jul 23, 2024 | — held |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 29.5K | 8.89% | 8.89% | $17.70M | Aug 9, 2024 | ▼ 5.1K |
REDWOOD FINANCIAL NETWORK CORP pharmaceutical preparations | 25.0K | 7.54% | 7.54% | $15.00M | Aug 7, 2024 | — held |
CHAPIN DAVIS, INC. pharmaceutical preparations | 20.0K | 6.03% | 6.03% | $12.00M | Jul 19, 2024 | — held |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. pharmaceutical preparations | 18.3K | 5.52% | 5.52% | $11.00M | Jul 26, 2024 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2024 vs prior quarter
Q2 2024
5
Increased
+34.0K shares2
New Positions
first time holders5
Decreased
−70.3K shares2
Sold Out
fully exitedNet shares change (top 50)
36.3K
+34.0K / −70.3K
Net new holders
+0
2 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ORGS insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
4
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Adler Yaron director | Dec 12, 2024 | Award | 1,750 | $0.98 | $1.7K | 1.8K | Form 4 ↗ |
PELAVIN ADAM director | Dec 12, 2024 | Award | 1,250 | $0.98 | $1.2K | 1.3K | Form 4 ↗ |
PELAVIN ADAM director | Dec 12, 2024 | Award | 625 | $0.98 | $612.5 | 625 | Form 4 ↗ |
Nanda Ashish director | Dec 12, 2024 | Award | 1,835 | $0.98 | $1.8K | 1.8K | Form 4 ↗ |
NAGARAJ SANTHOSH director | Dec 12, 2024 | Award | 1,250 | $0.98 | $1.2K | 1.3K | Form 4 ↗ |
NAGARAJ SANTHOSH director | Dec 12, 2024 | Award | 625 | $0.98 | $612.5 | 625 | Form 4 ↗ |
Vider Itzhak director | Dec 12, 2024 | Award | 1,500 | $0.98 | $1.5K | 1.5K | Form 4 ↗ |
BHALAJI JAGANNATHAN director | Dec 12, 2024 | Award | 1,250 | $0.98 | $1.2K | 1.3K | Form 4 ↗ |
BHALAJI JAGANNATHAN director | Dec 12, 2024 | Award | 625 | $0.98 | $612.5 | 625 | Form 4 ↗ |
Safier Jacob 10 percent owner | Apr 10, 2024 | Purchase | 10,000 | $0.59 | $5.9K | 3.12M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Orgenesis Inc. (ORGS) is primarily owned by institutional investors, who hold approximately 30.1% of total shares outstanding. Company insiders own approximately 33.22%, while retail and public investors account for the remaining 36.73%.
The largest institutional shareholder of Orgenesis Inc. is VANGUARD GROUP INC, holding approximately 910,250 shares — equal to 2.74% of outstanding shares — as of June 30, 2024.
A total of 18 institutional investors currently hold ORGS stock, with a combined institutional value of approximately $931,618 as of the most recent 13F filing period.
Frequently asked questions
ORGS ownershipOrgenesis Inc. (ORGS) is primarily owned by institutional investors, who hold approximately 30.1% of shares. The largest shareholder is VANGUARD GROUP INC with a 2.74% stake. Company insiders hold 33.22%. Data sourced from SEC Form 13F as of June 30, 2024.